ID   SOAT1_HUMAN             Reviewed;         550 AA.
AC   P35610; A6NC40; A8K3P4; A9Z1V7; B4DU95; Q5T0X4; Q8N1E4;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2003, sequence version 3.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Sterol O-acyltransferase 1;
DE            EC=2.3.1.26 {ECO:0000269|PubMed:18480028};
DE   AltName: Full=Acyl-coenzyme A:cholesterol acyltransferase 1;
DE            Short=ACAT-1;
DE   AltName: Full=Cholesterol acyltransferase 1;
GN   Name=SOAT1; Synonyms=ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-526.
RC   TISSUE=Macrophage;
RX   PubMed=8407899;
RA   Chang C.C.Y., Huh H.Y., Cadigan K.M., Chang T.-Y.;
RT   "Molecular cloning and functional expression of human acyl-coenzyme
RT   A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary
RT   cells.";
RL   J. Biol. Chem. 268:20747-20755(1993).
RN   [2]
RP   SEQUENCE REVISION TO 207.
RA   Chang C.C.Y., Chang T.-Y.;
RL   Submitted (MAY-1999) to UniProtKB.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PRELIMINARY TOPOLOGY.
RX   PubMed=10438503; DOI=10.1074/jbc.274.33.23276;
RA   Lin S., Cheng D., Liu M.S., Chen J., Chang T.-Y.;
RT   "Human acyl-CoA:cholesterol acyltransferase-1 in the endoplasmic
RT   reticulum contains seven transmembrane domains.";
RL   J. Biol. Chem. 274:23276-23285(1999).
RN   [8]
RP   SUBCELLULAR LOCATION, TOPOLOGY, ACTIVE SITE, DISULFIDE BOND, AND
RP   MUTAGENESIS OF SER-269 AND HIS-460.
RX   PubMed=16154994; DOI=10.1074/jbc.M508384200;
RA   Guo Z.Y., Lin S., Heinen J.A., Chang C.C., Chang T.Y.;
RT   "The active site His-460 of human acyl-coenzyme A:cholesterol
RT   acyltransferase 1 resides in a hitherto undisclosed transmembrane
RT   domain.";
RL   J. Biol. Chem. 280:37814-37826(2005).
RN   [9]
RP   CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF ASP-400; SER-456;
RP   HIS-460 AND TYR-518.
RX   PubMed=18480028; DOI=10.1194/jlr.M800131-JLR200;
RA   Das A., Davis M.A., Rudel L.L.;
RT   "Identification of putative active site residues of ACAT enzymes.";
RL   J. Lipid Res. 49:1770-1781(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   INTERACTION WITH UBIAD1.
RX   PubMed=23169578; DOI=10.1002/humu.22230;
RA   Nickerson M.L., Bosley A.D., Weiss J.S., Kostiha B.N., Hirota Y.,
RA   Brandt W., Esposito D., Kinoshita S., Wessjohann L., Morham S.G.,
RA   Andresson T., Kruth H.S., Okano T., Dean M.;
RT   "The UBIAD1 prenyltransferase links menaquione-4 synthesis to
RT   cholesterol metabolic enzymes.";
RL   Hum. Mutat. 34:317-329(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Catalyzes the formation of fatty acid-cholesterol
CC       esters, which are less soluble in membranes than cholesterol.
CC       Plays a role in lipoprotein assembly and dietary cholesterol
CC       absorption. In addition to its acyltransferase activity, it may
CC       act as a ligase.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + cholesterol = CoA + cholesterol
CC       ester. {ECO:0000269|PubMed:18480028}.
CC   -!- SUBUNIT: May form homo- or heterodimers. Interacts with UBIAD1.
CC       {ECO:0000269|PubMed:23169578}.
CC   -!- INTERACTION:
CC       P54274:TERF1; NbExp=2; IntAct=EBI-6621955, EBI-710997;
CC       Q9Y5Z9:UBIAD1; NbExp=3; IntAct=EBI-6621997, EBI-2819725;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:16154994}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:16154994}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P35610-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35610-2; Sequence=VSP_045331;
CC       Name=3;
CC         IsoId=P35610-3; Sequence=VSP_045330;
CC   -!- INDUCTION: Highly activated by the presence of cholesterol.
CC   -!- SIMILARITY: Belongs to the membrane-bound acyltransferase family.
CC       Sterol o-acyltransferase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L21934; AAC37532.2; -; mRNA.
DR   EMBL; AK290659; BAF83348.1; -; mRNA.
DR   EMBL; AK300551; BAG62257.1; -; mRNA.
DR   EMBL; AL451075; CAI12676.1; -; Genomic_DNA.
DR   EMBL; AL512326; CAI12676.1; JOINED; Genomic_DNA.
DR   EMBL; AL512326; CAI13574.1; -; Genomic_DNA.
DR   EMBL; AL451075; CAI13574.1; JOINED; Genomic_DNA.
DR   EMBL; CH471067; EAW91043.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91044.1; -; Genomic_DNA.
DR   EMBL; BC028940; AAH28940.1; -; mRNA.
DR   CCDS; CCDS1330.1; -. [P35610-1]
DR   CCDS; CCDS58047.1; -. [P35610-2]
DR   CCDS; CCDS58048.1; -. [P35610-3]
DR   PIR; A59038; A48026.
DR   RefSeq; NP_001239440.1; NM_001252511.1. [P35610-2]
DR   RefSeq; NP_001239441.1; NM_001252512.1. [P35610-3]
DR   RefSeq; NP_003092.4; NM_003101.5. [P35610-1]
DR   RefSeq; XP_011508213.1; XM_011509911.1. [P35610-1]
DR   UniGene; Hs.445588; -.
DR   ProteinModelPortal; P35610; -.
DR   BioGrid; 112529; 55.
DR   IntAct; P35610; 34.
DR   STRING; 9606.ENSP00000356591; -.
DR   BindingDB; P35610; -.
DR   ChEMBL; CHEMBL2782; -.
DR   DrugBank; DB00973; Ezetimibe.
DR   DrugBank; DB01094; Hesperetin.
DR   SwissLipids; SLP:000000702; -.
DR   iPTMnet; P35610; -.
DR   PhosphoSitePlus; P35610; -.
DR   SwissPalm; P35610; -.
DR   BioMuta; SOAT1; -.
DR   DMDM; 33302623; -.
DR   EPD; P35610; -.
DR   MaxQB; P35610; -.
DR   PaxDb; P35610; -.
DR   PeptideAtlas; P35610; -.
DR   PRIDE; P35610; -.
DR   DNASU; 6646; -.
DR   Ensembl; ENST00000367619; ENSP00000356591; ENSG00000057252. [P35610-1]
DR   Ensembl; ENST00000539888; ENSP00000441356; ENSG00000057252. [P35610-3]
DR   Ensembl; ENST00000540564; ENSP00000445315; ENSG00000057252. [P35610-2]
DR   GeneID; 6646; -.
DR   KEGG; hsa:6646; -.
DR   UCSC; uc001gml.4; human. [P35610-1]
DR   CTD; 6646; -.
DR   DisGeNET; 6646; -.
DR   GeneCards; SOAT1; -.
DR   HGNC; HGNC:11177; SOAT1.
DR   HPA; CAB009533; -.
DR   HPA; HPA047171; -.
DR   MIM; 102642; gene.
DR   neXtProt; NX_P35610; -.
DR   OpenTargets; ENSG00000057252; -.
DR   PharmGKB; PA36015; -.
DR   eggNOG; KOG0380; Eukaryota.
DR   eggNOG; COG5056; LUCA.
DR   GeneTree; ENSGT00530000063122; -.
DR   HOGENOM; HOG000020782; -.
DR   HOVERGEN; HBG058198; -.
DR   InParanoid; P35610; -.
DR   KO; K00637; -.
DR   OMA; WLNFTSE; -.
DR   OrthoDB; EOG091G0991; -.
DR   PhylomeDB; P35610; -.
DR   TreeFam; TF105767; -.
DR   BRENDA; 2.3.1.26; 2681.
DR   Reactome; R-HSA-171052; LDL-mediated lipid transport.
DR   SIGNOR; P35610; -.
DR   ChiTaRS; SOAT1; human.
DR   GeneWiki; SOAT1; -.
DR   GenomeRNAi; 6646; -.
DR   PRO; PR:P35610; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000057252; -.
DR   CleanEx; HS_ACAT1; -.
DR   CleanEx; HS_SOAT1; -.
DR   ExpressionAtlas; P35610; baseline and differential.
DR   Genevisible; P35610; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL.
DR   GO; GO:0034736; F:cholesterol O-acyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IDA:BHF-UCL.
DR   GO; GO:0004772; F:sterol O-acyltransferase activity; IDA:MGI.
DR   GO; GO:0033344; P:cholesterol efflux; IMP:BHF-UCL.
DR   GO; GO:0034435; P:cholesterol esterification; IDA:BHF-UCL.
DR   GO; GO:0042632; P:cholesterol homeostasis; TAS:BHF-UCL.
DR   GO; GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL.
DR   GO; GO:0010878; P:cholesterol storage; IMP:BHF-UCL.
DR   GO; GO:0010742; P:macrophage derived foam cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0042986; P:positive regulation of amyloid precursor protein biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:BHF-UCL.
DR   InterPro; IPR004299; MBOAT_fam.
DR   InterPro; IPR014371; Oat_ACAT_DAG_ARE.
DR   InterPro; IPR030687; Sterol_acyltranf_meta.
DR   PANTHER; PTHR10408; PTHR10408; 1.
DR   Pfam; PF03062; MBOAT; 1.
DR   PIRSF; PIRSF000439; Oat_ACAT_DAG_ARE; 1.
DR   PIRSF; PIRSF500230; Sterol_acyltranf_ACAT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Alternative splicing;
KW   Cholesterol metabolism; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Lipid metabolism; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Steroid metabolism;
KW   Sterol metabolism; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    550       Sterol O-acyltransferase 1.
FT                                /FTId=PRO_0000207640.
FT   TOPO_DOM      1    140       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    141    159       Helical. {ECO:0000255}.
FT   TOPO_DOM    160    181       Lumenal. {ECO:0000255}.
FT   TRANSMEM    182    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    224       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    225    243       Helical. {ECO:0000255}.
FT   TOPO_DOM    244    246       Lumenal. {ECO:0000255}.
FT   TRANSMEM    247    264       Helical. {ECO:0000255}.
FT   TOPO_DOM    265    501       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    502    517       Helical. {ECO:0000255}.
FT   TOPO_DOM    518    550       Lumenal. {ECO:0000255}.
FT   ACT_SITE    460    460       {ECO:0000269|PubMed:16154994}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   DISULFID    528    546       {ECO:0000269|PubMed:16154994}.
FT   VAR_SEQ       1     65       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045330.
FT   VAR_SEQ       1     59       MVGEEKMSLRNRLSKSRENPEEDEDQRNPAKESLETPSNGR
FT                                IDIKQLIAKKIKLTAEAE -> M (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045331.
FT   VARIANT     526    526       Q -> R (in dbSNP:rs13306731).
FT                                {ECO:0000269|PubMed:8407899}.
FT                                /FTId=VAR_052031.
FT   MUTAGEN     269    269       S->A,T: Nearly normal expression and
FT                                enzyme activity.
FT                                {ECO:0000269|PubMed:16154994}.
FT   MUTAGEN     269    269       S->L: No expression nor activity.
FT                                {ECO:0000269|PubMed:16154994}.
FT   MUTAGEN     400    400       D->N: Low expression, loss of enzymatic
FT                                activity. {ECO:0000269|PubMed:18480028}.
FT   MUTAGEN     456    456       S->A: Loss of enzymatic activity.
FT                                {ECO:0000269|PubMed:18480028}.
FT   MUTAGEN     460    460       H->A,C,N: Loss of enzymatic activity.
FT                                {ECO:0000269|PubMed:16154994}.
FT   MUTAGEN     518    518       Y->F: Loss of enzymatic activity.
FT                                {ECO:0000269|PubMed:18480028}.
SQ   SEQUENCE   550 AA;  64735 MW;  5F5ACD525D541DEE CRC64;
     MVGEEKMSLR NRLSKSRENP EEDEDQRNPA KESLETPSNG RIDIKQLIAK KIKLTAEAEE
     LKPFFMKEVG SHFDDFVTNL IEKSASLDNG GCALTTFSVL EGEKNNHRAK DLRAPPEQGK
     IFIARRSLLD ELLEVDHIRT IYHMFIALLI LFILSTLVVD YIDEGRLVLE FSLLSYAFGK
     FPTVVWTWWI MFLSTFSVPY FLFQHWATGY SKSSHPLIRS LFHGFLFMIF QIGVLGFGPT
     YVVLAYTLPP ASRFIIIFEQ IRFVMKAHSF VRENVPRVLN SAKEKSSTVP IPTVNQYLYF
     LFAPTLIYRD SYPRNPTVRW GYVAMKFAQV FGCFFYVYYI FERLCAPLFR NIKQEPFSAR
     VLVLCVFNSI LPGVLILFLT FFAFLHCWLN AFAEMLRFGD RMFYKDWWNS TSYSNYYRTW
     NVVVHDWLYY YAYKDFLWFF SKRFKSAAML AVFAVSAVVH EYALAVCLSF FYPVLFVLFM
     FFGMAFNFIV NDSRKKPIWN VLMWTSLFLG NGVLLCFYSQ EWYARQHCPL KNPTFLDYVR
     PRSWTCRYVF
//
